...
首页> 外文期刊>Spine >Surgical Site Infection, Readmission, and Reoperation After Posterior Long Segment Fusion
【24h】

Surgical Site Infection, Readmission, and Reoperation After Posterior Long Segment Fusion

机译:外科遗址感染,再长段融合后的再生和重新组合

获取原文
获取原文并翻译 | 示例
           

摘要

Study Design. Retrospective case series. Objective. We sought to identify risk factors associated with surgical site infection (SSI) after posterior long segment spinal fusion (PLSF). Summary of Background Data. Patients who undergo PLSF may be at elevated risk of SSI. Identifying factors associated with SSI in these operations can help risk stratify patients and tailor management. Methods. We analyzed PLSFs-seven or more levels-at our institution from 2000 to 2015. Data on patients' clinical characteristics, procedural factors, and antimicrobial management were collected. Multivariable analysis identified factors independently associated with outcomes of interest. Results. In 628 cases, SSI was associated with steroid use (P = 0.024, odds ratio [OR] = 2.54) and using cefazolin (P < 0.001, OR = 4.37) or bacitracin (P = 0.010, OR 3.49) irrigation, as opposed to gentamicin or other irrigation. Gram-positive infections were more likely with staged procedures (P = 0.021, OR 4.91) and bacitracin irrigation (P < 0.001, OR = 17.98), and less likely with vancomycin powder (P = 0.050, OR 0.20). Gram-negative infections were more likely with a history of peripheral arterial disease (P = 0.034, OR = 3.21) or cefazolin irrigation (P < 0.001, OR 25.47). Readmission was more likely after staged procedures (P = 0.003, OR = 3.31), cervical spine surgery (P = 0.023, OR = 2.28), or cefazolin irrigation (P = 0.039, OR = 1.85). Reoperation was more common with more comorbidities (P = 0.022, OR 1.09), staged procedures (P < 0.001, OR = 4.72), cervical surgeries (P = 0.013, OR = 2.36), more participants in the surgery (P = 0.011, OR = 1.06), using cefazolin (P < 0.001, OR = 3.12) or bacitracin (P = 0.009, OR = 3.15) irrigation, and higher erythrocyte sedimentation rate at readmission (P = 0.009, OR = 1.04). Washouts were more likely among patients with more comorbidities (P = 0.013, OR = 1.16), or who used steroids (P = 0.022, OR = 2.92), and less likely after cervical surgery (P = 0.028, OR = 0.24). Instrumentation removal was more common with bacitracin irrigation (p = 0.013, OR = 31.76). Conclusion. Patient factors, whether a procedure is staged, and choice of antibiotic irrigation affect the risk of SSI and ensuing management required.
机译:研究设计。回顾性病例系列。客观的我们试图确定与后路长段脊柱融合术(PLSF)后手术部位感染(SSI)相关的风险因素。背景数据摘要。接受PLSF的患者可能有较高的SSI风险。识别这些手术中与SSI相关的因素可以帮助患者进行风险分层和定制管理。方法。从2000年到2015年,我们分析了该机构七个或七个以上级别的PLSF。收集患者的临床特征、程序因素和抗菌药物管理方面的数据。多变量分析确定了与感兴趣的结果独立相关的因素。后果在628例患者中,SSI与使用类固醇(P=0.024,优势比[OR]=2.54)和使用头孢唑林(P<0.001,OR=4.37)或杆菌肽(P=0.010,或3.49)灌洗有关,与庆大霉素或其他灌洗相反。阶段性手术(P=0.021,或4.91)和杆菌肽冲洗(P<0.001,或17.98)更有可能引起革兰阳性感染,而万古霉素粉则不太可能引起革兰阳性感染(P=0.050,或0.20)。革兰氏阴性感染更可能有外周动脉疾病史(P=0.034,或=3.21)或头孢唑啉灌洗史(P<0.001,或25.47)。分期手术(P=0.003,OR=3.31)、颈椎手术(P=0.023,OR=2.28)或头孢唑林灌洗(P=0.039,OR=1.85)后再入院的可能性更大。再手术更常见于合并症较多(P=0.022或1.09)、分期手术(P<0.001或=4.72)、宫颈手术(P=0.013或=2.36)、手术参与者较多(P=0.011或=1.06)、使用头孢唑啉(P<0.001或=3.12)或杆菌肽(P=0.009或=3.15)冲洗,以及再入院时血沉率较高(P=0.009或=1.04)。合并症较多的患者(P=0.013,或=1.16)或使用类固醇的患者(P=0.022,或=2.92)更容易出现冲洗,宫颈手术后出现冲洗的可能性较小(P=0.028,或=0.24)。器械移除在杆菌肽冲洗中更常见(p=0.013,OR=31.76)。结论患者因素、手术是否分阶段进行以及抗生素冲洗的选择都会影响SSI的风险和随后需要的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号